226 related articles for article (PubMed ID: 23812240)
1. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.
Tobian AA; Grabowski MK; Serwadda D; Newell K; Ssebbowa P; Franco V; Nalugoda F; Wawer MJ; Gray RH; Quinn TC; Reynolds SJ;
J Infect Dis; 2013 Sep; 208(5):839-46. PubMed ID: 23812240
[TBL] [Abstract][Full Text] [Related]
2. Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals.
Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR;
J Infect Dis; 2016 May; 213(10):1573-8. PubMed ID: 26704611
[TBL] [Abstract][Full Text] [Related]
3. Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda.
Gianella S; Redd AD; Grabowski MK; Tobian AA; Serwadda D; Newell K; Patel EU; Kalibbala S; Ssebbowa P; Gray RH; Quinn TC; Reynolds SJ
J Infect Dis; 2015 Sep; 212(6):899-903. PubMed ID: 25743428
[TBL] [Abstract][Full Text] [Related]
4. Herpes Simplex Virus Type-2 Cervicovaginal Shedding Among Women Living With HIV-1 and Receiving Antiretroviral Therapy in Burkina Faso: An 8-Year Longitudinal Study.
Low AJ; Nagot N; Weiss HA; Konate I; Kania D; Segondy M; Meda N; van de Perre P; Mayaud P;
J Infect Dis; 2016 Mar; 213(5):731-7. PubMed ID: 26475931
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Genital Herpes Shedding in HIV/Herpes Simplex Virus 2-Coinfected Women during Antiretroviral Therapy Is Associated with an Increase in HIV Tissue Reservoirs and Potentially Promotes HIV Evolution.
Stinn T; Kuntz S; Varon D; Huang ML; Selke S; Njikan S; Ford ES; Dragavon J; Coombs RW; Johnston C; Bull ME
J Virol; 2020 Dec; 95(1):. PubMed ID: 33028713
[TBL] [Abstract][Full Text] [Related]
6. Increase in HSV shedding at initiation of antiretroviral therapy and decrease in shedding over time on antiretroviral therapy in HIV and HSV-2 infected persons.
Ford ES; Magaret AS; Spak CW; Selke S; Kuntz S; Corey L; Wald A
AIDS; 2018 Nov; 32(17):2525-2531. PubMed ID: 30289810
[TBL] [Abstract][Full Text] [Related]
7. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
[TBL] [Abstract][Full Text] [Related]
8. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels.
Nagot N; Ouedraogo A; Konate I; Weiss HA; Foulongne V; Defer MC; Sanon A; Becquart P; Segondy M; Sawadogo A; Van de Perre P; Mayaud P;
J Infect Dis; 2008 Jul; 198(2):241-9. PubMed ID: 18593294
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
10. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes.
LeGoff J; Weiss HA; Gresenguet G; Nzambi K; Frost E; Hayes RJ; Mabey DC; Malkin JE; Mayaud P; Belec L
AIDS; 2007 Jul; 21(12):1569-78. PubMed ID: 17630552
[TBL] [Abstract][Full Text] [Related]
11. Use of acyclovir for suppression of human immunodeficiency virus infection is not associated with genotypic evidence of herpes simplex virus type 2 resistance to acyclovir: analysis of specimens from three phase III trials.
Watson-Jones D; Wald A; Celum C; Lingappa J; Weiss HA; Changalucha J; Baisley K; Tanton C; Hayes RJ; Marshak JO; Gladden RG; Koelle DM
J Clin Microbiol; 2010 Oct; 48(10):3496-503. PubMed ID: 20702659
[TBL] [Abstract][Full Text] [Related]
12. High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
Perti T; Saracino M; Baeten JM; Johnston C; Diem K; Ocbamichael N; Huang ML; Selke S; Magaret A; Corey L; Wald A
J Acquir Immune Defic Syndr; 2013 Jun; 63(2):201-8. PubMed ID: 23542637
[TBL] [Abstract][Full Text] [Related]
13. Effects of genital ulcer disease and herpes simplex virus type 2 on the efficacy of male circumcision for HIV prevention: Analyses from the Rakai trials.
Gray RH; Serwadda D; Tobian AA; Chen MZ; Makumbi F; Suntoke T; Kigozi G; Nalugoda F; Iga B; Quinn TC; Moulton LH; Laeyendecker O; Reynolds SJ; Kong X; Wawer MJ
PLoS Med; 2009 Nov; 6(11):e1000187. PubMed ID: 19936044
[TBL] [Abstract][Full Text] [Related]
14. Health care seeking among men with genital ulcer disease in South Africa: correlates and relationship to human immunodeficiency virus-1 and herpes simplex virus type 2 detection and shedding.
Leichliter JS; Lewis DA; Sternberg M; Habel MA; Paz-Bailey G
Sex Transm Dis; 2011 Sep; 38(9):865-70. PubMed ID: 21844743
[TBL] [Abstract][Full Text] [Related]
15. Herpes Simplex [corrected] Virus Type 2 Shedding From Male Circumcision Wounds in Rakai, Uganda.
Grabowski MK; Kigozi G; Gray RH; Armour B; Manucci J; Serwadda D; Redd AD; Nalugoda F; Patel EU; Wawer MJ; Quinn TC; Tobian AA
J Infect Dis; 2015 Nov; 212(10):1613-7. PubMed ID: 25943201
[TBL] [Abstract][Full Text] [Related]
16. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa.
Delany S; Mlaba N; Clayton T; Akpomiemie G; Capovilla A; Legoff J; Belec L; Stevens W; Rees H; Mayaud P
AIDS; 2009 Feb; 23(4):461-9. PubMed ID: 19155993
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.
Serwadda D; Gray RH; Sewankambo NK; Wabwire-Mangen F; Chen MZ; Quinn TC; Lutalo T; Kiwanuka N; Kigozi G; Nalugoda F; Meehan MP; Ashley Morrow R; Wawer MJ
J Infect Dis; 2003 Nov; 188(10):1492-7. PubMed ID: 14624374
[TBL] [Abstract][Full Text] [Related]
18. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
[TBL] [Abstract][Full Text] [Related]
19. Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
Phipps W; Nakku-Joloba E; Krantz EM; Selke S; Huang ML; Kambugu F; Orem J; Casper C; Corey L; Wald A
J Infect Dis; 2016 Feb; 213(3):439-47. PubMed ID: 26486633
[TBL] [Abstract][Full Text] [Related]
20. Antiretroviral therapy is not associated with reduced herpes simplex virus shedding in HIV coinfected adults: an observational cohort study.
Tan DH; Raboud JM; Kaul R; Walmsley SL
BMJ Open; 2014 Jan; 4(1):e004210. PubMed ID: 24464523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
